Thousands of women battling an advanced form of womb cancer have been offered renewed hope after a new treatment was approved for widespread use on the NHS.
Currently, just 15 per cent of women diagnosed with advanced (stage four) endometrial cancer – which typically originates in the lining of the womb – survive for five years.